Is idxg stock paying a dividend?
No significant news for IDXG in the past two years. IDXG is not currently paying a regular dividend. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes.
Should you hold Interpace Biosciences (idxg) stock?
The consensus among Wall Street equities research analysts is that investors should "hold" Interpace Biosciences stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IDXG, but not buy additional shares or sell existing shares.
Is $idxg still expecting a big move next week?
$IDXG still expecting a big move, looks like next week. $7.5 million loan due 8/31, payable to Ampersand and 1315 Capital who own ~65% of the company. They are close to becoming EBITDA positive and wouldn't be surprised if this guided higher for 2nd half of year
Should I buy or sell Interpace Biosciences stock right now?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Interpace Biosciences in the last twelve months. There are curren...
When is Interpace Biosciences' next earnings date?
Interpace Biosciences is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for...
How were Interpace Biosciences' earnings last quarter?
Interpace Biosciences, Inc. (NASDAQ:IDXG) issued its quarterly earnings data on Monday, May, 16th. The business services provider reported ($0.52)...
Who are Interpace Biosciences' key executives?
Interpace Biosciences' management team includes the following people: Dr. Thomas W. Burnell Ph.D. , Pres, CEO & Director (Age 58, Pay $425k) Mr....
Who are some of Interpace Biosciences' key competitors?
Some companies that are related to Interpace Biosciences include Laboratory Co. of America (LH) , Quest Diagnostics (DGX) , DaVita (DVA) , Chem...
What other stocks do shareholders of Interpace Biosciences own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Interpace Biosciences investors own include Inovio Pharmac...
What is Interpace Biosciences' stock symbol?
Interpace Biosciences trades on the NASDAQ under the ticker symbol "IDXG."
What is Interpace Biosciences' stock price today?
One share of IDXG stock can currently be purchased for approximately $3.22.
How much money does Interpace Biosciences make?
Interpace Biosciences (NASDAQ:IDXG) has a market capitalization of $13.62 million and generates $41.31 million in revenue each year.
About Interpace Biosciences
Interpace Biosciences (NASDAQ:IDXG) Frequently Asked Questions
Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States.
What is the IDXG company?
1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Interpace Biosciences in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Interpace Biosciences stock.
How much did the Dow rise in 2019?
PARSIPPANY, NJ, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that it has been named one of the 50 Most Admired Companies of the Year by The Silico...
Component Grades
With stocks at all time highs and after the Dow rose more than 22% and the S&P 500 rose over 28% in 2019, many investors have yet to make many changes in the portfolios for what could be another solid 2...
IDXG Stock Summary
We have 9 different ratings for every stock to help you appreciate its future potential. You can unlock it all now.
IDXG Valuation Summary
IDXG has a higher market value than just 3.57% of US stocks; more precisely, its current market capitalization is $21,039,213.
